175 related articles for article (PubMed ID: 22971472)
1. A randomized, prospective pilot study of patient expectancy and antidepressant outcome.
Rutherford BR; Marcus SM; Wang P; Sneed JR; Pelton G; Devanand D; Duan N; Roose SP
Psychol Med; 2013 May; 43(5):975-82. PubMed ID: 22971472
[TBL] [Abstract][Full Text] [Related]
2. Optimizing patient expectancy in the pharmacologic treatment of major depressive disorder.
Zilcha-Mano S; Brown PJ; Roose SP; Cappetta K; Rutherford BR
Psychol Med; 2019 Oct; 49(14):2414-2420. PubMed ID: 30420001
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant study design affects patient expectancy: a pilot study.
Rutherford B; Sneed J; Devanand D; Eisenstadt R; Roose S
Psychol Med; 2010 May; 40(5):781-8. PubMed ID: 19732481
[TBL] [Abstract][Full Text] [Related]
4. Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials.
Rutherford BR; Wall MM; Brown PJ; Choo TH; Wager TD; Peterson BS; Chung S; Kirsch I; Roose SP
Am J Psychiatry; 2017 Feb; 174(2):135-142. PubMed ID: 27609242
[TBL] [Abstract][Full Text] [Related]
5. Neural mechanisms of expectancy-based placebo effects in antidepressant clinical trials.
Zilcha-Mano S; Wang Z; Peterson BS; Wall MM; Chen Y; Wager TD; Brown PJ; Roose SP; Rutherford BR
J Psychiatr Res; 2019 Sep; 116():19-25. PubMed ID: 31176108
[TBL] [Abstract][Full Text] [Related]
6. Trajectories of depression severity in clinical trials of duloxetine: insights into antidepressant and placebo responses.
Gueorguieva R; Mallinckrodt C; Krystal JH
Arch Gen Psychiatry; 2011 Dec; 68(12):1227-37. PubMed ID: 22147842
[TBL] [Abstract][Full Text] [Related]
7. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
Papakostas GI; Fava M
Eur Neuropsychopharmacol; 2009 Jan; 19(1):34-40. PubMed ID: 18823760
[TBL] [Abstract][Full Text] [Related]
8. Can people with nonsevere major depression benefit from antidepressant medication?
Stewart JA; Deliyannides DA; Hellerstein DJ; McGrath PJ; Stewart JW
J Clin Psychiatry; 2012 Apr; 73(4):518-25. PubMed ID: 22226407
[TBL] [Abstract][Full Text] [Related]
9. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.
Furey ML; Drevets WC
Arch Gen Psychiatry; 2006 Oct; 63(10):1121-9. PubMed ID: 17015814
[TBL] [Abstract][Full Text] [Related]
11. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.
Sinyor M; Levitt AJ; Cheung AH; Schaffer A; Kiss A; Dowlati Y; Lanctôt KL
J Clin Psychiatry; 2010 Mar; 71(3):270-9. PubMed ID: 20122371
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo.
Fourrier C; Sampson E; Mills NT; Baune BT
Trials; 2018 Aug; 19(1):447. PubMed ID: 30126458
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.
Segal ZV; Bieling P; Young T; MacQueen G; Cooke R; Martin L; Bloch R; Levitan RD
Arch Gen Psychiatry; 2010 Dec; 67(12):1256-64. PubMed ID: 21135325
[TBL] [Abstract][Full Text] [Related]
14. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
[TBL] [Abstract][Full Text] [Related]
15. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
[TBL] [Abstract][Full Text] [Related]
17. A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder.
Mathew SJ; Gueorguieva R; Brandt C; Fava M; Sanacora G
Neuropsychopharmacology; 2017 Dec; 42(13):2567-2574. PubMed ID: 28553836
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
[TBL] [Abstract][Full Text] [Related]
19. The role of patient expectancy in placebo and nocebo effects in antidepressant trials.
Rutherford BR; Wall MM; Glass A; Stewart JW
J Clin Psychiatry; 2014 Oct; 75(10):1040-6. PubMed ID: 25006812
[TBL] [Abstract][Full Text] [Related]
20. A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression.
Keitner GI; Garlow SJ; Ryan CE; Ninan PT; Solomon DA; Nemeroff CB; Keller MB
J Psychiatr Res; 2009 Jan; 43(3):205-14. PubMed ID: 18586273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
